Inventor · disambiguated record
Mónica Torres Rosa
Also filed as: ROSA MONICA · ROSA MONICA TORRES · ROSA MÓNICA · ROSA MÓNICA TORRES
6 granted patents·15 pending applications·28 citations·filing 2010–2023
80Inventor score
Files withSUBLIMITY THERAPEUTICS LTD10SIGMOID PHARMA LTD7AIC246 AG & CO KG2AVERSA VINCENZO1COULTER IVAN1
Top patents by PatentIndex Score
21 records- 0190US9220681B2FormulationsSIGMOID PHARMA LTD·Filed 2013·Granted Dec 29, 2015·9 cites·48 claims
- 0284US9950051B2FormulationsSIGMOID PHARMA LTD·Filed 2015·Granted Apr 24, 2018·2 cites·81 claims
- 0383US9878036B2Immunomodulatory compositions comprising a polymer matrix and an oil phaseCOULTER IVAN·Filed 2010·Granted Jan 30, 2018·9 cites·64 claims
- 0480US2024091304A1Formulations comprising cyclosporin aSUBLIMITY THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0576US10434138B2FormulationsSUBLIMITY THERAPEUTICS LTD·Filed 2014·Granted Oct 8, 2019·3 cites·28 claims
- 0676US2024100122A1FormulationsSUBLIMITY THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0775US9821024B2Immunomodulatory compositionsAVERSA VINCENZO·Filed 2011·Granted Nov 21, 2017·5 cites·8 claims
- 0869US2021386817A1Formulations comprising cyclosporin aSUBLIMITY THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0967US2022080026A1FormulationsSUBLIMITY THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1066US2024082349A1Compositions comprising cyclosporinSUBLIMITY THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1163US2015132374A1FormulationsSIGMOID PHARMA LTD·Filed 2014·Application pending·0 cites
- 1263US2016317609A1Formulations comprising cyclosporin aSIGMOID PHARMA LTD·Filed 2014·Application pending·0 cites
- 1363US2018360909A1Formulations comprising cyclosporin aSIGMOID PHARMA LTD·Filed 2018·Application pending·0 cites
- 1461US2019192619A1FormulationsSUBLIMITY THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 1558US2019381131A1FormulationsSUBLIMITY THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1656US2022062374A1Compositions comprising cyclosporinSUBLIMITY THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1752US10993987B2Compositions comprising CyclosporinSUBLIMITY THERAPEUTICS LTD·Filed 2015·Granted May 4, 2021·0 cites·33 claims
- 1847US2018042989A1Immunomodulatory compositionsSIGMOID PHARMA LTD·Filed 2017·Application pending·0 cites
- 1947US2023138444A1Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and sodium ionsAIC246 AG & CO KG·Filed 2021·Application pending·0 cites
- 2047US2023095980A1Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and pharmaceutical compositions thereofAIC246 AG & CO KG·Filed 2021·Application pending·0 cites
- 2145US2018071387A1Immunomodulatory compositions comprising a polymer matrix and an oil phaseSIGMOID PHARMA LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mónica Torres Rosa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →